BOOK
Moderate Preterm, Late Preterm, and Early Term Births, An Issue of Clinics in Perinatology, E-Book
(2013)
Additional Information
Book Details
Abstract
This issue is expected to be in high demand, being extremely valuable to both neonatologists and maternal-fetal medicine physicians. The Guest Editors have put together a very comprehensive issue that looks at the premature infant. Topics include: Moderate Preterm. Late Preterm and Early Term Births: Epidemiology and Trends; Stillbirth Reduction Efforts and Impact on Early Births; Management of Indicated Early Term and Late Preterm Births; Physiological Underpinnings for Clinical Problems in Moderately Preterm, Late Preterm;Brain Maturation in the Second of Half of Pregnancy; Respiratory Disorders in Moderately Preterm, Late Preterm and Early Term Infants; Metabolic and Neurologic Issues in Moderately Preterm, Late Preterm and Early Term Infants; and Quality Initiatives Related to Moderately Preterm, Late Preterm and Early Term Births.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Moderate Preterm,Late Preterm andEarly Term Births | i | ||
Copyright\r | ii | ||
Contributors | iii | ||
Contents | vii | ||
Forthcoming Issues | xiii | ||
The Tug of War Between Stillbirths and Elective Early Births | xv | ||
References | xviii | ||
Late Preterm and Early Term Births | xix | ||
References | xx | ||
Epidemiology of Moderate Preterm, Late Preterm and Early Term Delivery | 601 | ||
Key points | 601 | ||
Introduction | 601 | ||
Prevalence rates and temporal trends of moderate preterm, late preterm, and early term deliveries | 602 | ||
Recurrence of moderate preterm and late preterm deliveries | 603 | ||
Risk factors for moderate preterm, late preterm, and early term deliveries | 606 | ||
Adverse infant outcomes associated with delivery from 32 to 38 weeks' gestation | 606 | ||
Moderate Preterm Birth (32–33 Weeks) | 606 | ||
Late Preterm Birth (34–36 Weeks) | 606 | ||
Early Term Birth (37–38 Weeks) | 607 | ||
Summary | 607 | ||
References | 607 | ||
Stillbirth Reduction Efforts and Impact on Early Births | 611 | ||
Key points | 611 | ||
Introduction | 611 | ||
Implications of late preterm or early term delivery | 612 | ||
Pregnancies at increased risk for stillbirth | 615 | ||
Hypertension | 615 | ||
Diabetes | 616 | ||
Intrauterine Growth Restriction | 617 | ||
Multiple Gestations | 618 | ||
Placental Abnormalities | 619 | ||
Fetal Abnormalities | 620 | ||
Prior Stillbirth | 620 | ||
Abnormal Fetal Testing | 621 | ||
Knowledge gaps | 621 | ||
Summary | 621 | ||
References | 625 | ||
Early Births and Congenital Birth Defects | 629 | ||
Key points | 629 | ||
Introduction and historical perspective | 629 | ||
Birth defects causing early birth | 630 | ||
Chromosomal Defects | 631 | ||
Polyhydramnios | 631 | ||
Congenital Infections | 632 | ||
Early elective delivery secondary to birth defects | 633 | ||
Multiple Gestation | 633 | ||
Gastrointestinal Defects | 635 | ||
Congenital Heart Disease | 636 | ||
Growth Issues | 636 | ||
Maternal conditions associated with birth defects and early birth | 637 | ||
Obesity | 637 | ||
Diabetes | 637 | ||
Depression | 638 | ||
Behavioral Factors | 639 | ||
Summary | 639 | ||
References | 640 | ||
Physiologic Underpinnings for Clinical Problems in Moderately Preterm and Late Preterm Infants | 645 | ||
Key points | 645 | ||
Introduction | 645 | ||
Thermoregulation | 646 | ||
Respiratory morbidities | 646 | ||
RDS | 647 | ||
TTN | 647 | ||
Hypoxic Respiratory Failure | 647 | ||
Pneumonia | 648 | ||
Autonomic Regulation, Control of Breathing, and Apnea of Prematurity | 648 | ||
Immunologic immaturity and infections | 648 | ||
Glucose homeostasis | 653 | ||
Gastrointestinal immaturity and feeding | 654 | ||
Hepatic immaturity and hyperbilirubinemia | 655 | ||
Brain dysmaturity and risk for periventricular leukomalacia | 657 | ||
Summary | 658 | ||
References | 658 | ||
Respiratory Disorders in Moderately Preterm, Late Preterm, and Early Term Infants | 665 | ||
Key points | 665 | ||
Epidemiology | 665 | ||
Fetal lung development and neonatal respiratory transition | 667 | ||
Respiratory morbidities | 671 | ||
Long-term risk of respiratory disorders | 673 | ||
Acknowledgments | 674 | ||
References | 674 | ||
Jaundice and Kernicterus in the Moderately Preterm Infant | 679 | ||
Key points | 679 | ||
Introduction | 679 | ||
Scope of the problem | 680 | ||
Mechanism of brain injury | 681 | ||
Clinical manifestations of hyperbilirubinemia in the moderately preterm infant | 682 | ||
Clinical management of hyperbilirubinemia in the moderately preterm infant | 682 | ||
Future directions | 685 | ||
Summary | 685 | ||
Acknowledgments | 685 | ||
References | 685 | ||
Management of Breastfeeding During and After the Maternity Hospitalization for Late Preterm Infants | 689 | ||
Key points | 689 | ||
Late preterm infants and mothers: a population at risk for poor lactation outcomes | 690 | ||
Suction Pressures and Milk Removal During Breastfeeding in Late Preterm Infants | 691 | ||
Lactation Risk for Mothers of Late Preterm Infants | 692 | ||
Late preterm infants cared for in the maternity setting should not be considered healthy term infants | 693 | ||
Management of breastfeeding for late preterm infants and mothers | 694 | ||
The Maternity Hospital Stay | 694 | ||
Preparing for Hospital Discharge | 695 | ||
Lactation Technologies Suitable for Mothers and LPIs | 695 | ||
Protecting milk volume | 695 | ||
Facilitating milk intake during breastfeeding | 697 | ||
Ensuring adequate milk intake during breastfeeding | 697 | ||
Discontinuing Lactation Technologies for Mothers and LPIs | 699 | ||
Adequacy of Exclusive Human Milk for MPIs, LPIs, and ETIs | 699 | ||
Summary | 700 | ||
References | 700 | ||
Neuropathologic Studies of the Encephalopathy of Prematurity in the Late Preterm Infant | 707 | ||
Key points | 707 | ||
Introduction | 708 | ||
Brain development in the second half of human gestation | 709 | ||
The encephalopathy of prematurity further defined | 710 | ||
The encephalopathy of prematurity in the late preterm infant | 711 | ||
Periventicular Leukomalacia (PVL) in the Late Preterm Infant at Autopsy | 711 | ||
Reactive Gliosis and Activated Microglia in the Cerebral White Matter in EP in Late Preterm Infants at Autopsy | 712 | ||
Gray Matter Lesions in EP in Late Preterm Infants at Autopsy | 713 | ||
Thalamic Damage in EP in Late Preterm Infants at Autopsy | 716 | ||
Deficit of Neurons in the Cerebral White Matter in EP in Late Term Infants at Autopsy | 717 | ||
Summary | 718 | ||
References | 719 | ||
Neurologic and Metabolic Issues in Moderately Preterm, Late Preterm, and Early Term Infants | 723 | ||
Key points | 723 | ||
Intracranial hemorrhage | 724 | ||
Periventricular leukomalacia | 726 | ||
Apnea | 727 | ||
Maturation of feeding ability | 727 | ||
Hypoxic-ischemic encephalopathy | 731 | ||
Perinatal stroke | 732 | ||
Control of breathing and thermoregulation | 733 | ||
Summary | 734 | ||
References | 734 | ||
Long-Term Outcomes of Moderately Preterm, Late Preterm, and Early Term Infants | 739 | ||
Key points | 739 | ||
Background | 739 | ||
Maternal factors | 740 | ||
Neonatal characteristics | 740 | ||
Postdischarge medical problems | 740 | ||
Neurodevelopmental outcome studies | 741 | ||
Newborn to Preschool | 741 | ||
Early School Age | 744 | ||
Adolescents and Adults | 746 | ||
Early term infants | 748 | ||
Summary | 748 | ||
References | 749 | ||
Hospital Readmissions and Emergency Department Visits in Moderate Preterm, Late Preterm, and Early Term Infants | 753 | ||
Key points | 753 | ||
Kaiser Permanente—primary data collection | 762 | ||
KPNC cohort | 763 | ||
Hospital readmissions and diagnoses | 763 | ||
Readmission age | 766 | ||
Temporal trends in readmission rates | 767 | ||
Emergency department visits and diagnoses | 768 | ||
ED visit age | 768 | ||
Risk factors for hospital readmissions and ED visits | 769 | ||
Summary | 771 | ||
References | 772 | ||
Appendix\r | 775 | ||
Quality Initiatives Related to Moderately Preterm, Late Preterm, and Early Term Births | 777 | ||
Key points | 777 | ||
Introduction | 777 | ||
OPQC | 778 | ||
OPQC Neonatal Initiatives | 779 | ||
Reducing late-onset infections | 779 | ||
Human milk | 779 | ||
OPQC Obstetrics Initiatives | 783 | ||
Thirty-nine weeks delivery project | 783 | ||
Thirty-nine weeks delivery/birth records accuracy | 783 | ||
Antenatal corticosteroids | 785 | ||
Areas for future QI initiatives | 785 | ||
Delaying Preterm Birth | 785 | ||
Progesterone | 785 | ||
Admission/Level of Care | 786 | ||
Respiratory Management | 786 | ||
Infection Reduction | 787 | ||
Feeding Management | 787 | ||
Discharge Planning | 787 | ||
Summary | 788 | ||
Acknowledgments | 788 | ||
References | 788 | ||
Moderately Preterm, Late Preterm and Early Term Infants | 791 | ||
Key points | 791 | ||
Introduction | 791 | ||
Some aspects of developmental maturation | 792 | ||
Definition and epidemiology | 792 | ||
Obstetric issues | 793 | ||
Neonatal issues | 793 | ||
Cardiovascular and Pulmonary Systems | 794 | ||
Nervous System | 794 | ||
Metabolic | 794 | ||
Nutrition, Breastfeeding and Lactation, and the Gastrointestinal System | 794 | ||
Immunology and Sepsis | 795 | ||
Renal and Genitourinary Systems | 795 | ||
Development Pharmacology | 795 | ||
Miscellaneous | 795 | ||
Summary | 795 | ||
References | 796 | ||
Index | 799 |